Irish Residential Properties REIT

Pre-Annual General Meeting Information • Apr 11, 2025

THIS DOCUMENT AND ACCOMPANYING FORM OF PROXY ARE IMPORTANT AND REQUIRE YOUR IMMEDIATE ATTENTION.

If you are in any doubt about the course of action to take, you should immediately consult your independent professional adviser, being, in the case of Irish resident shareholders, an organisation or firm authorised or exempt under the Investment Intermediaries Act 1995 (as amended) of Ireland or an authorised investment firm within the meaning of the European Union (Markets in Financial Instruments) Regulations 2017 (as amended) or another appropriately authorised professional adviser if you are resident in a territory outside Ireland.

If you sell or otherwise transfer, or if you have sold or otherwise transferred all of your shares in Irish Residential Properties REIT plc, please forward this document and accompanying documents (but not the personalised Form of Proxy) to the purchaser or transferee of such shares or to the stockbroker, bank or the agent through whom the sale or transfer is being or was effected, for onward transfer to the purchaser or transferee. If you sell or otherwise transfer, or if you have sold or otherwise transferred some of your shares, you should immediately consult the stockbroker, bank or other agent through whom the sale or transfer is or was effected for the onward transfer to the relevant purchaser or transferee for the course of action you should take.

Irish Residential Properties REIT plc Annual General Meeting

15 May 2025

Your attention is drawn to the letter from the Chair of Irish Residential Properties REIT plc ("I-RES" or the "Company") which is set out on pages 2 to 7 of this document, and which contains the recommendation of the Board to shareholders of the Company (the "Shareholders") to vote in favour of the resolutions to be proposed at the Annual General Meeting referred to below. You should read this document in its entirety when considering whether to vote in favour of the resolutions.

Notice convening the Annual General Meeting of the Company to be held at the Herbert Park Hotel, Ballsbridge, Dublin 4, D04 R2T2, Ireland on Thursday, 15 May 2025 at 9.30 a.m. and related Statement of Procedures are set out on pages 8 to 17 of this document.

I-RES is delighted to invite Shareholders to attend the Annual General Meeting in person again this year.

Shareholders are also invited to submit their votes in respect of the resolutions to be put to Shareholders at the Annual General Meeting either through completion and submission of a Form of Proxy (as enclosed), or by the other means described in this document. The process of appointing a proxy will depend on the manner in which you hold your ordinary shares in the Company. Details of how to do this (and how to submit questions in advance of, or at, the meeting) are provided in the Statement of Procedures to the Notice of Annual General Meeting set out on pages 13 to 17 of this document.

All references to time in this document are references to Dublin time unless otherwise stated.

IRISH RESIDENTIAL PROPERTIES REIT PUBLIC LIMITED COMPANY

(Registered in the Republic of Ireland, Registered Number 529737)

Directors

Hugh Scott-Barrett, Non-Executive Chair (UK) Eddie Byrne, Chief Executive Officer, Executive Director Joan Garahy, Non-Executive and Senior Independent Director Amy Freedman, Non-Executive Director (Canada) Denise Turner, Non-Executive Director Phillip Burns, Non-Executive Director (UK and USA) Richard Nesbitt, Non-Executive Director (Canada) Stefanie Frensch, Non-Executive Director (Germany) Tom Kavanagh, Non-Executive Director

Company Secretary Anna-Marie Curry

Registered Office

South DockHouse Hanover Quay Dublin 2 D02W94

11 April 2025

To the shareholders of Irish Residential Properties REIT plc ("I-RES" or the "Company"), (the "Shareholders")

Dear Shareholder,

1. Introduction

I am pleased to inform you that the Annual General Meeting of the Company will be held at the Herbert Park Hotel, Ballsbridge, Dublin 4, D04 R2T2, Ireland on Thursday, 15 May 2025 at 9.30 a.m.

Your attention is drawn to the Notice of Annual General Meeting of the Company, set out on pages 8 to 12 of this document, which sets out the resolutions to be proposed at the Meeting.

2. Business of the meeting and the Board's recommendations

All of the resolutions proposed this year, with the exception of Resolution 11, deal with business of the Company that has been considered and approved by Shareholders at previous annual general meetings. In addition to those resolutions, Shareholders are being asked (under Resolution 11) to consider a proposal to amend the Company's Articles of Association to extend the notice period that Shareholders must provide to the Company when nominating a director for election to the Board. This is being proposed in order to facilitate Shareholder engagement on any such resolution and to overcome technical issues arising on certain electronic voting platforms where sufficient notice of the nomination resolution is not received. These items of business are set out in Resolutions 1 to 11 (inclusive) of the Notice of Annual General Meeting. A summary and explanation of those resolutions is also set out further below.

The Board considers all of the Resolutions to be proposed at the Annual General Meeting to be in the best interests of the Company and its Shareholders. Accordingly, the Directors unanimously recommend that Shareholders vote for the Resolutions as they intend to do in respect of their own shareholdings.

3. Resolutions proposed for consideration at the Annual General Meeting

Ordinary Business

Resolution 1 – Receipt and consideration of the Financial Statements

This is an ordinary resolution to receive and consider the financial statements of the Company for the year ended 31 December 2024 together with the Directors' and the Auditor's reports thereon. A copy of the 2024 Annual Report is available at www.iresreit.ie.

Resolution 2 – Directors

Resolutions 2(a) to 2(h) address the election and re-election of Directors.

In line with best practice under the Irish Corporate Governance Code published by Euronext Dublin and in accordance with the Company's Articles of Association, all existing Directors, will retire from office at the Annual General Meeting and, with the exception of Phillip Burns, being eligible, offer themselves for re-election by Shareholders at the Annual General Meeting.

As set out in the 2024 Annual Report, Phillip Burns, having served 9 years on the Board, will retire as a Director of the Company on the expiry of his current term at the 2025 Annual General Meeting and will therefore not stand for re-election. We are grateful to Phillip for his outstanding contribution and commitment to the Board and would like to wish him every success for the future. The Board is of the view that a Board of 9 Directors is not optimal for the size of the Company, therefore we do not intend to replace Phillip on the Board when he retires.

The performance of each of the Directors appointed to the Board during the year ended 31 December 2024 has been formally evaluated by the Board and each is considered by the Board to continue to be an effective member of the Board and to demonstrate commitment to their role. An overview of the performance evaluation process carried out by the Board for the year ended 31 December 2024 is set out in the Nomination Committee Report, in the section entitled 'Board Evaluation' of the 2024 Annual Report.

Biographical information in respect of each such Director is set out in the section entitled 'Board of Directors' of the 2024 Annual Report. The Board believes that the experience and expertise included in the biographies demonstrates the continued contribution of each Director to the Company and the Board considers each Director is, and continues to be, important to the Company's long-term sustainable success. As in prior years, the 2024 Annual Report also includes a skills matrix for the Directors of the Board which provides further insight into the diversity of experience the Board possesses. The matrix is disclosed in the Corporate Governance Report in the section entitled 'Board Composition' of the 2024 Annual Report.

Each of Resolutions 2(a) – (h) is proposed separately as an ordinary resolution in respect of each Director.

The Board considers the election and re-election of these Directors to be in the best interests of the Company and Shareholders.

Resolution 3 – Consent to Short Notice of Extraordinary General Meeting

Section 1102 of the Companies Act 2014 (as amended) (the "Companies Act 2014") provides that a company may, on an annual basis, pass a special resolution such as this Resolution 3 to preserve its ability to call general meetings (other than an annual general meeting or a meeting for the passing of a special resolution), where appropriate, using a shorter notice period of 14 clear days' notice (as opposed to the statutory 21 clear days' notice). The Directors consider that it is in the interests of the Company to preserve this flexibility and renew this authority again this year. However, as a matter of policy, the Company will only call a general meeting on 14 clear days' notice where the Directors believe that it is merited by the business of the meeting and the circumstances surrounding the business. If passed, this authority will be effective until the next annual general meeting of the Company, when it is intended that a resolution renewing this authority will again be proposed.

Resolution 4 – Continuation in office of the Auditor

Section 383 of the Companies Act 2014 provides for the automatic re-appointment of the auditor of an Irish company at the Company's annual general meeting unless the auditor has given notice in writing of its unwillingness to be re-appointed or a resolution has been passed at that meeting appointing a new auditor or providing expressly that the incumbent auditor shall not be re-appointed. The Company's Auditor, KPMG, has indicated a willingness to continue in office. However, the Directors believe that it is important that Shareholders are provided with an opportunity to have a say on the continuation in office of the Company's Auditor each year and have included Resolution 4, which is an advisory non-binding resolution, for this purpose.

Resolution 5 – Auditor's remuneration

This is an ordinary resolution proposed each year which asks Shareholders to renew the Directors' authority to fix the Auditor's remuneration.

Special Business

Resolution 6 – Advisory resolution on the Report of the Remuneration Committee on Directors' Remuneration

This is an ordinary resolution asking Shareholders to receive and consider the report prepared by the Remuneration Committee for the Company on Directors' remuneration (other than the Remuneration Policy) for the year ended 31 December 2024 as set out in the Section entitled Annual Remuneration Report for 2024 in the 2024 Annual Report (the "Remuneration Report"), which is available to view at www.iresreit.ie.

This resolution is put to Shareholders in line with the requirements of the European Union (Shareholders' Rights Regulations) 2020 (the "Irish SRD II Regulations") which requires the Company to present a remuneration report to Shareholders for consideration at each annual general meeting. Resolution 6 is being put to Shareholders as an advisory non- binding resolution.

The Remuneration Policy, as set out on pages 126 to 133 of the 2023 Annual Report, is not required to be approved at this year's AGM as it was approved by Shareholders at the 2024 annual general meeting in accordance with the requirements of the Irish SRD II Regulations.

Resolutions 7, 8(a), 8(b), 9 and 10 – Share Capital

The next five items of special business relate to the share capital of the Company and concern matters, which are now considered standard for most listed public companies in Ireland.

Resolution 7 – Authority to allot shares

Each year, an ordinary resolution is proposed to renew the general authority of the Directors to allot and issue new shares in the Company. This year, Resolution 7 proposes to renew the general authority of the Directors to allot shares up to an aggregate nominal value of €26,387,303, representing approximately 50% of the nominal value of the Company's issued share capital as at 3 April 2025 (the latest practicable date prior to the publication of this document).

It is the Directors' intention that any allotment pursuant to Resolution 7 exceeding one third of the nominal value of the issued share capital would be made pursuant to a fully pre-emptive rights issue only (subject to exclusions for legal and/or practical issues including fractional entitlements and jurisdictional issues). The Directors will exercise this authority only if they consider it to be in the best interests of the Shareholders generally at the relevant time. This authority is in line with general market trends and with institutional shareholder guidance, in particular the Investment Association guidelines on Directors' authority to allot shares.

The Directors have no present intention of making any issue of shares pursuant to this authority if approved by Shareholders.

Resolutions 8(a) and 8(b) – Authority to dis-apply pre-emption rights

In November 2022, the Pre-Emption Group published a revised Statement of Principles (the "Statement of Principles"), which increased the guideline threshold for the annual disapplication of pre-emption rights authorities from 10% to 20% of a company's issued share capital, with some additional flexibility for follow-on offers of up to a maximum of an additional 4% of a company's issued share capital in specified circumstances.

This year, the Directors are seeking authority under Resolutions 8(a) and 8(b) for the disapplication of pre-emption rights up to a maximum of 10% of the Company's issued share capital only.

The Board considers that these resolutions continue to be in the best interests of the Company and its Shareholders and are necessary to afford flexibility (albeit at the lower level of 10%) to raise capital if needed, and so the Board has resolved to table these resolutions again at the 2025 AGM.

Although there is currently no intention to make use of these powers, the Directors consider that it is in the interests of Shareholders for the Directors to have this limited flexibility to allot shares without having first to offer them to existing Shareholders. The Directors would exercise this power only if they consider it to be in the best interests of Shareholders generally at that time having regard, in particular, to market conditions and the prevailing share price. If the Company were to allot shares utilising these authorities, it would follow the shareholder protections in Part 2B of the Statement of Principles.

Accordingly, Resolution 8(a) is a special resolution authorising the Directors to disapply statutory pre-emption rights in the event of the allotment of "equity securities" (essentially ordinary shares in the Company) for cash. This disapplication is limited to allotments (i) in connection with any rights issue, open offer or other pro-rata offer to Shareholders generally (subject to exclusions for legal and/or practical issues including fractional entitlements and jurisdictional issues) and (ii) otherwise in an amount with an aggregate nominal value of up to €2,638,730.34 representing 5% of the nominal value of the issued share capital of the Company as at 3 April 2025 (the latest practicable date prior to the publication of this document).

Resolution 8(b) is a special resolution authorising the Directors, in addition to the authority granted under Resolution 8(a), to disapply statutory pre-emption rights in the event of the allotment, for cash, of "equity securities" with an aggregate nominal value of up to €2,638,730.34, representing a further 5% of the nominal value of the issued share capital of the Company as at 3 April 2025 (the latest practicable date prior to the publication of this document) for the purposes of what the Directors determine to be an acquisition or other specified capital investment which is announced contemporaneously with the issue, or which has taken place in the preceding 12 month period and is disclosed in the announcement of the issue.

The expression "specified capital investment" is defined by the Statement of Principles as one or more specific capital investment related uses for the proceeds of an issuance of equity securities, in respect of which sufficient information regarding the effect of the transaction on the listed company, the assets the subject of the transaction and (where appropriate) the profits attributable to them is made available to Shareholders to enable them to reach an assessment of the potential return. Items that are regarded as operating expenditure rather than capital expenditure will not typically be regarded as falling within the term "specified capital investment".

This disapplication of pre-emption rights in respect of a further 5% of the Company's issued share capital is in line with the recommendations of the Statement of Principles which supports the annual disapplication of pre-emption rights in respect of allotments of shares and other equity securities for cash up to a further aggregate amount of up to 10% of the nominal value of the Company's issued ordinary share capital (exclusive of treasury shares) to be used in connection with an acquisition or specified capital investment.

Resolution 8(a) and Resolution 8(b) are each proposed as separate special resolutions. The division of the authorisation to allot equity securities into two resolutions is in conformity with the Statement of Principles and good practice template resolutions as published by the Pre-Emption Group in November 2022.

Resolution 9 – Authorisation of market purchases of the Company's shares

Resolution 9 is a special resolution to renew the authority of the Company (and its subsidiaries) to purchase up to 15% of the Company's own issued shares. In addition, this authority provides for a maximum and minimum price at which such purchases may be made, which prices have been set in line with market practice in this regard. The authority being sought under this resolution would permit any shares so purchased either to be cancelled or held as treasury shares.

As previously announced, the Company launched a share buyback programme on 20 March 2025 for the purchase of its ordinary shares for a maximum aggregate consideration of up to €5 million the "Buyback Programme"). It is expected that the Buyback Programme will end no later than 31 May 2025, subject to market conditions. The Buyback Programme is currently operating under the shareholder authority granted to the Company at the 2024 Annual General Meeting which authorised purchases of up to 15% of the Company's issued share capital. To the extent that the Buyback Programme has not concluded by the date of the AGM on 15 May 2025, then the Buyback Programme will continue to operate under the renewed authority (under Resolution 9), if granted. If Shareholders do not renew this authority, the Buyback Programme will terminate on the day of the AGM in those circumstances. It is important therefore that Shareholders vote in favour of this resolution at the AGM.

Outside of the Buyback Programme, the Directors have no present intention to exercise this authority (if granted) and it will be exercised only if the Directors consider it would be in the best interests of the Shareholders generally, after taking into account the Company's overall financial position.

Resolution 10 – Setting the re-allotment price of market purchases of the Company's shares

Resolution 10 is a special resolution to approve the price range at which shares purchased by the Company (treasury shares) may be re-allotted. The maximum price at which a treasury share may be re-allotted off-market pursuant to Resolution 10 is an amount equal to 120% of the Appropriate Price (as defined in Resolution 9).

The authority in each of Resolutions 7, 8(a), 8(b), 9 and 10 will expire on the earlier of the conclusion of the next annual general meeting of the Company after the passing of such resolution (or, in the case of Resolution 9, at the close of trading on the date of the 2026 annual general meeting) or the date which is 15 calendar months after the passing of such resolution, whichever occurs first, unless and to the extent varied, revoked or renewed prior to such date.

Resolution 11 – Amendment to Articles of Association

Resolution 11 is a special resolution seeking to amend article 94 of the Company's Articles of Association.

Article 94, which relates to eligibility of persons for appointment to the office of director of the Company, currently provides inter alia that "No person other than a Director retiring by rotation shall be appointed a Director at any general meeting unless (i) he is recommended by the Directors or (ii) not less than 7 (seven) nor more than 30 (thirty) Clear Days before the date appointed for the meeting, notice executed by a Member qualified to vote at the meeting has been given to the Company of the intention to propose that person……".

The Company recognises the importance of providing duly qualified members the opportunity to put forward candidates for election as a director of the Company and always welcomes the opportunity to interact with its Shareholders on these matters. However, the right currently afforded by Article 94 means that any such proposals may be submitted after the dispatch of the notice convening the relevant general meeting, and potentially just seven days before the meeting. This may therefore mean that Shareholders and proxy advisers would not have sufficient time and information to come to a conclusion on the merits of any such proposals.

In addition, following the replacement of CREST with Euroclear Bank for electronic settlement of trading in our ordinary shares in 2021, the vast majority of our Shareholders hold their interests through the Euroclear system and therefore have much earlier voting deadlines imposed by the voting platforms they use, often up to one week before a general meeting. The process of adding additional resolutions to the voting options available through those voting platforms is not straightforward and is outside the control of the Company. Accordingly, should a valid nomination be received during the period following the dispatch of the notice of general meeting, the Company cannot guarantee that it would have sufficient time to seek to procure the updating of those voting platforms to allow Shareholders using those platforms to vote on those additional resolutions.

For these reasons, it is proposed that the notice period for receipt by the Company of any notice of intention to propose a director from a shareholder referred to in Article 94 of the Company's Articles of Association is amended so that any such notice must be received not less than 42 days, nor more than 70 days, before the date appointed for the relevant general meeting. The proposed amendment to the minimum required notice period would align Article 94 of the Articles of Association with the statutory minimum notice period prescribed by section 1104(2) of the Companies Act 2014 which provides that a request to put an item on the agenda or to table a draft resolution must be received by a company at least 42 days before the date of the meeting to which it relates. In addition, for the reasons explained above, this proposed amendment would ensure that relevant details of any proposed candidate for election as a director could be included in the relevant notice of meeting, that Shareholders and proxy advisers would have time to consider (and in the case of proxy advisers, advise on) the merits of the proposed candidate and that electronic voting on any potential candidate for election can be facilitated.

A copy of the Articles of Association in the form amended by Resolution 11 (marked to highlight the proposed changes) is available (and will be available until the conclusion of the AGM) on the Company's website (www.iresreit.ie), at its registered office and will also be available at the AGM for at least fifteen minutes before, and for the duration of, the AGM.

4. Attendance at the Annual General Meeting

The Company welcomes Shareholders to attend and vote at the Annual General Meeting in person again this year. Should Shareholders choose not to physically attend this year's AGM, Shareholders can avail of the proxy voting service to ensure they can vote on the resolutions proposed at the Annual General Meeting and be represented at the Annual General Meeting. By submitting a proxy as soon as possible, you can ensure that your vote on the resolutions set out in the Notice of Annual General Meeting is cast in accordance with your wishes without attending in person. Details of how to do this are provided in the Statement of Procedures set out on pages 13 to 17 of this document.

On behalf of the Board, I thank you for your continued support.

Yours sincerely,

Hugh Scott-Barrett Chair

IRISH RESIDENTIAL PROPERTIES REIT PLC

NOTICE OF ANNUAL GENERAL MEETING

Notice is hereby given that the Annual General Meeting of Irish Residential Properties REIT plc (the "Company") will be held at the Herbert Park Hotel, Ballsbridge, Dublin 4, D04 R2T2, Ireland on Thursday, 15 May 2025 at 9.30 a.m. for the below purposes.

Resolutions 1, 2(a) – (h), 4, 5, 6, and 7 are proposed as ordinary resolutions. Resolutions 3, 8(a), 8(b), 9, 10 and 11 are proposed as special resolutions.

References to the Companies Act 2014 in this Notice of Annual General Meeting shall be read in all cases as a reference to the Companies Act 2014 (as amended).

Ordinary Business

• 1. To receive and consider the financial statements of the Company for the year ended 31 December 2024 and the reports of the Directors and Auditor thereon (Resolution 1).
• 2. The following resolutions 2 (a) to (h), each being separate ordinary resolutions (Resolutions 2 (a) – (h)):
  • (a) To re-elect as a Director Hugh Scott-Barrett, who is retiring in accordance with the Articles of Association and, being eligible, offers himself for election;
  • (b) To re-elect as a Director Eddie Byrne, who is retiring in accordance with the Articles of Association and, being eligible, offers himself for election;
  • (c) To re-elect as a Director Joan Garahy, who is retiring in accordance with the Articles of Association and, being eligible, offers herself for election;
  • (d) To re-elect as a Director, Amy Freedman, who is retiring in accordance with the Articles of Association and, being eligible, offers herself for election;
  • (e) To re-elect as a Director, Denise Turner, who is retiring in accordance with the Articles of Association and, being eligible, offers herself for election;
  • (f) To re-elect as a Director, Richard Nesbitt, who is retiring in accordance with the Articles of Association and, being eligible, offers himself for election;
  • (g) To re-elect as a Director, Stefanie Frensch, who is retiring in accordance with the Articles of Association and, being eligible, offers herself for election; and
  • (h) To re-elect as a Director, Tom Kavanagh, who is retiring in accordance with the Articles of Association and, being eligible, offers himself for election.
• 3. To consider and, if thought fit, to pass the following as a special resolution (Resolution 3):

That, in accordance with and subject to Section 1102 of the Companies Act 2014, the Directors be, and they are hereby generally and unconditionally authorised to call a general meeting, other than an annual general meeting or a meeting for the passing of a special resolution, on not less than 14 clear days' notice. The authority hereby conferred shall expire at the conclusion of the next annual general meeting of the Company after the date of passing of this resolution unless and to the extent previously renewed, varied or revoked by the Company in generalmeeting.

• 4. To consider the continuation in office of KPMG as Auditor of the Company until the conclusion of the next annual general meeting of the Company (Resolution 4).
• 5. To authorise the Directors to fix the remuneration of the Auditor in respect of the period expiring at the next annual general meeting of the Company (Resolution 5).

Special Business

• 6. To receive and consider the Report of the Remuneration Committee on Directors' Remuneration for the year ended 31 December 2024 (other than the Remuneration Policy) in the Section entitled Annual Remuneration Report for 2024 in the Company's 2024 Annual Report (Resolution 6).
• 7. To consider and, if thought fit, to pass the following as an ordinary resolution (Resolution 7):

That, the Directors be and they are hereby generally andunconditionally authorised, pursuantto Section 1021 of the Companies Act 2014, to exercise all of the powers of the Company to allot and issue all relevant securities (within the meaning of Section 1021 of the Companies Act 2014) of the Company:

• (a) without prejudice to or limitation of any power and authority granted pursuant to paragraph (b) of this Resolution 7, up to an aggregate nominal value of €17,589,776.45 representing approximately 33.33% of the aggregate nominal value of the issued ordinary share capital of the Company as at 5 p.m. on 3 April 2025; and
• (b) without prejudice to or limitation of any power and authority granted under paragraph (a) of this Resolution 7, up to an aggregate nominal value of €8,797,526.95 representing a further approximately 16.67% of the aggregate nominal value of the issued ordinary share capital of the Company as at 5 p.m. on 3 April 2025 provided that any equity securities (within the meaning of Section 1023(1) of the Companies Act 2014) allotted pursuant to the authority in this paragraph 7(b) are offered by way of one or more rights issues for a period(s) fixed by the Directors to or in favour of the holders of equity securities on the register of members and/or any persons having a right to subscribe for equity securities in the capital of the Company at such record date(s) as the Directors may determine and where the equity securities respectively attributable to the interests of such holders and persons are proportional in nominal value (as nearly as may be practicable) to the respective number of equity securities held by them on such record date(s), and subject generally, but without limitation to any of the foregoing, to such exclusions or other arrangements as the Directors may consider necessary or expedient in relation to legal and/or practical issues (including to deal with any fractional entitlements and/or arising in respect of overseas members and/or jurisdictional issues) under the laws of, or the requirements of any regulatory body or stock exchange in, anyterritory.

The authority hereby conferred under this Resolution 7 shall commence at the time of the passing of this resolution and shall expire at the conclusion of the next annual general meeting of the Company after the passing of this resolution or close of business on the date which is 15 calendar months after the date of passing this resolution, whichever is earlier, unless and to the extent that such power is varied, revoked, or renewed prior to such date; provided that the Company may before such expiry make offer(s) and/or agreement(s) which would or might require relevant securities to be allotted after such expiry, and the Directors may allot relevant securities in pursuance of any such offer(s) and/or agreement(s) as if the power conferred hereby had not expired.

• 8. To consider and, if thought fit, to pass the following special resolutions, each being separate special resolutions:
  • (a) To consider and, if thought fit, to pass the following as a special resolution (Resolution 8(a)):

That, subject to the passing of Resolution 7 and for the purposes of Sections 1022 and 1023(3) of the Companies Act 2014, the Directors be and are hereby generally and unconditionally empowered, in addition to and without prejudice to or limitation of any power and/or authority granted pursuant to Resolution 8(b), to allot equity securities (within the meaning of Section 1023(1) of the Companies Act 2014) for cash pursuant to and in accordance with the authority conferred pursuant to Resolution 7 and/or the Articles of Association of the Company as if Section 1022(1) of the Companies Act 2014 did not apply to such allotment, to include the re-allotment of any treasury shares from time to time, provided that the powers conferred by this resolution shall be limited to:

(i) the allotment of equity securities in connection with any one or more issues or offerings to or in favour of holders of equity securities and/or any other persons entitled to participate in such issue or offering (other than the Company itself in respect of any shares held by it as treasury shares) at such record date(s) as the Directors may determine where the equity securities respectively attributable to the interests of such holders and persons are proportionate in nominal value (as nearly as may be practicable) to the respective number of equity securities held by or deemed to be held by them on the record date(s) of such allotment(s) and subject thereto to the allotment in any case by way of placing or otherwise of any equity securities not taken up in such issues or offerings as the Directors may determine; and generally subject only to such exclusions or other arrangements as the Directors may consider necessary or expedient in relation to any legal and/or practical issues (including to deal with any fractional entitlements and/or arising in respect of overseas members and/or jurisdictional issues) under the laws or requirements of any regulatory body or stock exchange in any territory; and

(ii) the allotment, other than on foot of the power conferred by sub-paragraph (i) above, of equity securities up to an aggregate nominal value of €2,638,730.34, representing 5% of the issued ordinary share capital of the Company as at 5 p.m. on 3 April 2025,

provided that the power hereby conferred shall expire on the earlier of the conclusion of the next annual general meeting of the Company after the passing of this resolution or the close of business on the date which is 15 calendar months after the passing of this special resolution unless and to the extent varied, revoked or renewed prior to such date in accordance with the provisions of the Companies Act 2014, save that the Company may, before such expiry, make offer(s) and/or agreement(s) which would or might require equity securities to be allotted or issued after such expiry and the Directors may allot equity securities in pursuance of any such offer (s) and/or agreement(s) as if the power hereby conferred had not expired.

(b) To consider and, if thought fit, to pass the following as a special resolution (Resolution 8(b)):

That, subject to the passing of Resolution 7, for the purposes of Sections 1022 and 1023(3) of the Companies Act 2014, the Directors be and are hereby generally and unconditionally empowered, in addition to and without prejudice to or limitation of any power and/or authority granted pursuant to Resolution 8(a), to allot equity securities (within the meaning of Section 1023(1) of the Companies Act 2014) for cash pursuant to and in accordance with the authority conferred pursuant to Resolution 7 and/or the Articles of Association of the Company as if Section 1022(1) of the Companies Act 2014 did not apply to such allotment, to include the re-allotment of any treasury shares from time to time, provided that the powers conferred by this resolution shall be limited to:

• (i) the allotment of equity securities up to an aggregate nominal value of €2,638,730.34, representing 5% of the issued ordinary share capital of the Company as at 5 p.m. on 3 April 2025; and
• (ii) where the proceeds of the allotment are to be used only for the purposes of financing (or refinancing, if the authority is to be used within 12 months after the original transaction) a transaction which the Directors determine to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group and in effect prior to the date of the notice containing this resolution,

provided that the power hereby conferred shall expire on the earlier of the conclusion of the next annual general meeting of the Company after the passing of this resolution or the close of business on the date which is 15 calendar months after the passing of this special resolution unless and to the extent revoked, varied or renewed prior to such date in accordance with the provisions of the Companies Act 2014, save that the Company may, before such expiry, make offer(s) and/or agreement(s) which would or might require equity securities to be allotted or issued after such expiry and the Directors may allot equity securities in pursuance of any such offer(s) and/or agreement(s) as if the power hereby conferred had not expired.

9. To consider and, if thought fit, to pass the following as a special resolution (Resolution 9):

That the Company and any subsidiary of the Company for the time being be and they are each hereby generally and unconditionally authorised to make market purchases including overseas market purchases (in each case within the meaning of Section 1072 of the Companies Act 2014), of any ordinary shares in the share capital of the Company (including any contract of purchase, which will or might be concluded wholly or partly after the expiry date below) on such terms and conditions and in such manner as the Directors may determine from time to time subject to the provisions of the Companies Act 2014, provided that:

• (a) the aggregate nominal value of ordinary shares which may be acquired pursuant to the terms of this resolution shall not exceed €7,916,191.02, representing 15% of the issued ordinary shares in the share capital of Company as at 5 p.m. on 3 April 2025;
• (b) the maximum price (excluding expenses) at which a purchase pursuant to this authorisation will be made will be the higher of:
  • (i) 105% of the "Appropriate Price" as defined below; and
  • (ii) the amount stipulated by Article 3(2) of Commission Delegated Regulation (EU) 2016/1052 adopted by the European Commission pursuant to Article 5 of Regulation No. 596/2014 of the European Parliament and Council (being the value of an ordinary share calculated on the basis of the higher of the price quoted for:
    • a. the last independent trade of; and
    • b. the highest current independent bid or offer for,

any number of ordinary shares on the trading venue where the purchase pursuant to the authority conferred by this resolution will be carried out);

• (c) the minimum price (excluding expenses), which may be paid for ordinary shares purchased pursuant to this authorisation will be an amount equal to the nominal value thereof;and
• (d) this authority expires at close of trading on the earlier of the date of the next annual general meeting of the Company after the passing of this resolution or the close of business on the date which is 15 calendar months after the passing of this special resolution unless and to the extent varied, revoked or renewed by special resolution prior to such date, save that the Company may make a purchase after the expiry of the authorisation in any case where the contract of purchase is executed wholly or partly before the authorisation expired and may complete any such contract as if the authority conferred had not expired.

For the purpose of Resolution 9 and Resolution 10, the "Appropriate Price" is the average of the five amounts resulting from determining whichever of the following (I), (II) or (III) specified below in relation to shares of the class of which such treasury share is to be re-issued shall be appropriate in respect of each of the five business days immediately preceding the day on which the treasury share is re-issued, as determined from information on the business done published in the Daily Official List in Dublin of the Irish Stock Exchange plc (trading as Euronext Dublin) relating to each of these five businessdays:

• I. if there shall be more than one dealing reported for the day, the average of the prices at which such dealings took place; or
• II. if there shall be only one dealing reported for the day, the price at which such dealing took place; or
• III. if there shall not be any dealing reported for the day, the average of the high and low market guide prices for the day,

and if there shall be only a high (but not a low) or a low (but not a high) market guide price reported, or if there shall not be any market guide price reported, for any particular day, then that day shall not count as one of the said five business days for the purposes of determining the "Appropriate Price". If the means of providing the foregoing information as to dealings and prices by reference to which the "Appropriate Price" is to be determined is altered or is replaced by some other means, then the "Appropriate Price" is to be determined on the basis of the equivalent information published by the relevant authority in relation to dealings published in the Daily Official List in Dublin of the Irish Stock Exchange plc (trading as Euronext Dublin) or its equivalent.

10. To consider and, if thought fit, to pass the following as a special resolution (Resolution 10):

That the Directors be and are hereby generally and unconditionally authorised pursuant to Section 1021 of the Companies Act 2014 to re-allot treasury shares (within the meaning of Section 106 of the Companies Act 2014) as relevant securities and pursuant to Section 1023 of the Companies Act 2014, to re-allot treasury shares as equity securities as if Section 1022(1) of the Companies Act 2014 did not apply to any such reallotment provided that:

(a) this power shall be subject to the limits provided by Resolutions 7, 8(a) and 8(b) and shall expire on the earlier of the conclusion of the next annual general meeting of the Company after the passing of this resolution or the close of business on the date which is 15 calendar months after the passing of this special resolution unless and to the extent varied, revoked or renewed by special resolution prior to such date, save that the Company may before such expiry make offer(s) and/or agreement(s), which would or might require such re-allotment to occur after such expiry and the Directors may re-allot securities pursuant to any such offer(s) and/or agreement(s) as if the power conferred hereby had not expired;

• (b) the price range at which any treasury shares may be re-allotted off market for the purposes of Section 109 or Section 1078 of the Companies Act 2014 shall be as follows:
  • (i) the maximum price at which a treasury share may be re-allotted off-market shall be an amount equal to 120% of the Appropriate Price, as defined in Resolution 9 above;
  • (ii) in the case of re-allotments of shares other than to satisfy entitlements under the Company's LTIP, share options or employees' share schemes, the minimum price at which a treasury share may be re-allotted off-market shall be not less than 95% of the Appropriate Price, as defined in Resolution 9 above (provided always that no treasury share shall be issued at a price lower than its nominal value); or
  • (iii) in the case of re-allotments of shares to satisfy entitlements under the Company's LTIP, share options or employees' share schemes, the minimum price at which a treasury share may be re-allotted off-market shall be an amount equal to the nominal value thereof.
• 11. To consider and, if thought fit, to pass the following as a special resolution (Resolution 11):

That Article 94 of the Articles of Association of the Company be deleted and replaced with a new Article 94 as follows:

"No person other than a Director retiring by rotation shall be appointed a Director at any general meeting unless (i) he/she is recommended by the Directors or (ii) not less than 42 (forty-two) days nor more than 70 (seventy) days before the date appointed for the meeting, notice executed by a Member qualified to vote at the meeting has been given to the Company of the intention to propose that person for appointment stating, with respect to such person to be proposed, the particulars which would be required, if he/she were so appointed, to be included in the Company's register of Directors together with notice executed by that person of his/her willingness to be appointed."

By Order of the Board.

Anna-Marie Curry Secretary Irish Residential Properties REIT plc South Dock House Hanover Quay Dublin 2 D02 XW94 Ireland

Dated: 11 April 2025

STATEMENT OF PROCEDURES

1. Entitlement to attend and vote

Only those Shareholders of the Company registered on the Company's register of members at 6 p.m. on Sunday, 11 May 2025 (being the day which is four days prior to the AGM) (the "Record Date") or if the AGM is adjourned, at 6 p.m. on the day four days prior to the adjourned AGM, shall be entitled to attend, speak, ask questions and, in respect of the number of shares in the Company registered in their name at that time, vote at the meeting, or, if relevant, any adjournment thereof. Changes to entries on that register after that time and date shall be disregarded in determining the rights of any person to attend and vote at the meeting.

2. Availability of documents and information in connection with the meeting on the Company's website Information regarding the AGM, including the full, unabridged text of the documents and resolutions to be submitted to the meeting and the information required to be made available by Section 1103(3) of the Companies Act 2014, is available from www.iresreit.ie/investors/shareholder-meetings.

3. Attending in person

The AGM will be held at the Herbert Park Hotel, Ballsbridge, Dublin 4, D04 R2T2, Ireland on Thursday, 15 May 2025 at 9.30 a.m. The Company welcomes Shareholders to attend the AGM in person. If it becomes necessary or appropriate to revise the current arrangements for the AGM, further information will be made available by Regulatory Information Service and on our website at www.iresreit.ie.

If you wish to attend the AGM in person, you are recommended to attend at least 15 minutes before the time appointed for holding of the AGM to allow time for registration. Please bring the Attendance Card attached to your Form of Proxy and present it at the shareholder registration desk before the commencement of the AGM.

4. Appointment of proxies

Following the migration of the holding and settlement of uncertificated shares in the Company from the CREST system ("CREST") to the system operated by Euroclear Bank SA/NV ("Euroclear Bank"), ("EB System") on 15 March 2021, the process of appointing a proxy will depend on the manner in which you hold your ordinary shares in the Company.

• Shareholders whose name appears on the register of members of the Company (being those who do not hold their interests in ordinary shares as Belgian law rights through the EB System or as CREST depository interests ("CDIs") through the CREST system) and who are entitled to attend and vote at the AGM, may appoint (by electronic means or in writing) one or more proxies to attend, speak and vote on his or her behalf at the AGM. Please see notes (5) to (7) and (10) below in this regard.
• Electronic proxy voting in respect of the ordinary shares registered in the name of Euroclear Nominees Limited ("Euroclear Nominees") as nominee for Euroclear Bank will occur through the use of a secured mechanism to exchange electronic messages as agreed by the Company with Euroclear Bank.
• Persons who hold their interests in ordinary shares as Belgian law rights through the EB System ("EB Participants") or as CDIs through CREST ("CDI Holders") should read notes (8) to (11) below (which is based on the information available to the Company as at 3 April 2025, the latest practicable date prior to the publication of this document) and should consult with their stockbroker or other intermediary at the earliest opportunity for further information on the processes and timelines for submitting proxy appointments and voting instructions for the AGM through the respective systems.
• For voting services offered by custodians holding Irish corporate securities directly with Euroclear Bank, please contact your custodian.

5. Appointment of proxies - identity and multiple proxies

A proxy need not be a Shareholder. A Shareholder may appoint more than one proxy to attend on the same occasion and vote in respect of shares held in different securities accounts. A Shareholder acting as an intermediary on behalf of one or more clients may grant a proxy to each of its clients or their nominees and such intermediary may cast votes attaching to some of the shares differently from other shares held by it. If you wish to appoint more than one proxy please contact the Company's Registrar, Computershare Investor Services (Ireland) Limited at 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland or telephone +353 1 447 5511. The appointment of a proxy will not preclude a Shareholder from attending, speaking, asking questions and voting at the meeting should the Shareholder wish to do so.

6. Appointment of Proxy by the Form of Proxy

A Form of Proxy for use by Shareholders is enclosed with this Notice of Annual General Meeting (or is otherwise being delivered to Shareholders). Completion of a Form of Proxy (or submission of proxy instructions electronically) will not prevent a Shareholder from attending or speaking at the AGM or voting in person should they wish to do so.

To be valid, a Form of Proxy, duly signed and any power of attorney or other valid authority, if any, under which it is signed (or a copy of such authority certified notarially) must be returned by post to the Company's Registrar, Computershare Investor Services (Ireland) Limited, at 3100 Lake Drive, Citywest Business Campus, Dublin 24, D24 AK82, Ireland as soon as possible and in any event by no later than 9.30 a.m. on Tuesday, 13 May 2025 or (in the case of a poll taken otherwise than at or on the same day as the AGM or adjourned AGM) at least 48 hours before the taking of the poll at which it is to be used.

7. Electronic Appointment of Proxy

Shareholders who wish to appoint (or remove) proxies by electronic means may do so by accessing the Registrars' website www.eproxyappointment.com . To do so, Shareholders will need their Control Number, Shareholder Reference Number (SRN) and PIN, which are printed on the enclosed Form of Proxy. Full details of the procedures, including voting instructions, are given on the website www.eproxyappointment.com .

8. Further information for EB Participants

EB Participants can submit proxy appointments (including voting instructions) electronically in the manner described in the document issued by Euroclear Bank in December 2023 and entitled "Euroclear Bank as issuer CSD for Irish corporate securities".

EB Participants can either send:

• electronic voting instructions to instruct Euroclear Nominees (as sole registered shareholder of all ordinary shares held through the Euroclear system) to either itself, or by appointing the chair as proxy, to:
  • vote in favour of all or a specific resolution(s);
  • vote against all or a specific resolution(s);
  • abstain from all or a specific resolution(s);
  • give a discretionary vote to the Chair in respect of one or more of the resolutions being put to a shareholder vote; or
• a proxy voting instruction to appoint a third party (other than Euroclear Nominees/the chair of the meeting) to attend the meeting.

Voting instructions cannot be changed or cancelled after Euroclear Bank's voting deadline. There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third-party proxy appointment instructions.

EB Participants are strongly encouraged to familiarise themselves with the arrangements with Euroclear Bank, including the voting deadlines and procedures.

9. Further information for CREST members with holdings of CDIs

Euroclear UK & International Limited ("EUI"), the operator of CREST has arranged for CDI Holders to issue voting instructions relating to the Company's ordinary shares via a third-party service provider, Broadridge Financial Solutions Limited ("Broadridge"). Further details on this service are set out on the "All you need to know about SRD II in Euroclear UK & International" webpage (see section CREST International Service – Proxy voting). CREST members can complete and submit electronic voting instructions or proxy appointment instructions electronically throughBroadridge.

CDI Holders will be required to make use of the Euroclear UK & International proxy voting service facilitated on EUI's behalf by Broadridge Global Proxy Voting service in order to receive meeting announcements and send back voting instructions as required. In addition, if you wish to submit electronic voting instructions or proxy appointment instructions you must use the Broadridge Global Proxy Voting service. To avail of the voting service, you will need to complete the Meetings and Voting Client Set-up Form (CRT408) prescribed by Broadridge and return it with a completed application form to EUI (signed by an authorised signatory with another relevant authorised signatory copied for verification purposes) to the following email address: eui.srd2@euroclear.com . Fully completed application forms will be shared by EUI with Broadridge and Broadridge will contact you and provide information on its service and enable access to the Broadridge platform.

The voting service will process and deliver proxy voting instructions received from CREST members on the Broadridge voting deadline date to Euroclear Bank, by its cut-off and to agreed market requirements. The same voting options as described above for EB Participants will be available (i.e. electronic votes by means of Chair proxy appointments or appointing a third party proxy).

Broadridge will set a voting deadline by which time electronic voting instructions or proxy appointment instructions must be received by it for use at the AGM. Broadridge's voting deadline will be earlier than the Euroclear Bank's voting instruction deadline and is expected to be close of business two business days before Euroclear Bank's voting instruction deadline.

CDI Holders should pay close attention to any notices specifically relating to this AGM and are strongly encouraged to familiarise themselves with Broadridge's arrangements, including voting deadlines and procedures, and to take any further actions required by Broadridge so that they can avail of this voting service.

CDI Holders are additionally advised that any acquisition of shares which are expected to settle after the Broadridge voting deadline and before the Record Date will be settled on the basis that the purchaser may be unable to exercise any underlying voting or attendance rights.

Broadridge will use best endeavours to accept late votes, changes and cancellations from a CDI Holder after the voting deadline but there is no guarantee that these will be processed within the requisite timeframes.

There is no facility to offer a letter of representation/appoint a corporate representative other than through the submission of third-party proxy appointment instructions.

10. Deadlines for receipt by the Company of Proxy Voting Instructions

All proxy appointments and voting instructions (whether submitted directly or through the EB System or (via a holding of CDIs) (CREST) must be received by the Registrar not less than 48 hours before the time appointed for the AGM or any adjournment of the AGM. However, persons holding through the EB System or (via a holding of CDIs) CREST will also need to comply with any additional voting deadlines imposed by their respective custodian, stockbroker or other intermediary. All persons affected are recommended to consult with their custodian, stockbroker or other intermediary at the earliest opportunity.

11. Issued shares and total voting rights

The total number of issued shares as at 5 p.m. on 3 April 2025 (the latest practicable date prior to the publication of this Notice of Annual General Meeting) was 527,746,068, and as at that time and date, the Company does not hold any treasury shares.

On a vote by show of hands, every Shareholder who is present in person or by a duly authorised representative of a corporate shareholder or by proxy has one vote (but no individual shall have more than one vote). On a poll, every Shareholder shall have one vote for every share carrying rights of which he, she or it is the holder. On a poll a Shareholder, whether present in person or by a duly authorised representative of a corporate shareholder or by proxy, entitled to more than one vote need not, if the Shareholder votes, use all his, her or its votes or cast all the votes the Shareholder uses in the same way.

Save for advisory resolutions which are non-binding resolutions, the resolutions proposed for adoption at the AGM comprise ordinary resolutions requiring a simple majority of Shareholders voting in person or by proxy or by a duly authorised representative of a corporate shareholder to be passed and special resolutions which require not less than 75% of Shareholders voting in person or by proxy or by a duly authorised representative of a corporate shareholder to be passed.

12. Questions at the AGM

Under Section 1107 of the Companies Act 2014, each Shareholder has the right to ask questions related to items on the agenda of the general meeting and to have such questions answered by the Company subject to any reasonable measures the Company may take to ensure the identification of the member, unless:

• answering the question would interfere unduly with the preparation for the AGM or the confidentiality and business interests of the Company;
• the answer has already been given on the Company's website by means of a question and answer forum; or
• it appears to the Chair of the AGM that it is undesirable in the interests of good order of the meeting that the question be answered.

Shareholders will be able to attend the AGM and ask a question in person. However, to further facilitate shareholder communication, we invite Shareholders who are entitled to attend the AGM and who wish to submit questions relating to items on the agenda of the AGM in accordance with their rights under Irish law, to do so in advance by emailing the secretary of the Company at companysecretary@iresreit.ie. Questions must be received no later than 9.30 a.m. on Tuesday, 13 May 2025. All correspondence should include sufficient information to identify a Shareholder on the Register of Members (for example, a shareholder reference number, which is an 11-digit unique identifier printed on the Form of Proxy enclosed with this Notice of Annual General Meeting (or otherwise being delivered to Shareholders)). The answers to validly posed questions will be answered at the AGM.

13. Shareholders' right to put items on the agenda of the AGM

Under Section 1104 of the Companies Act 2014, a Shareholder or Shareholders meeting the qualification criteria set out below have the right to request that an item be put on the agenda of the AGM. Such a request may be made by a Shareholder or Shareholders holding 3 per cent of the issued share capital, representing at least 3 per cent of the total voting rights of all the Shareholders who have a right to vote at the AGM.

The request:

• may be in hard copy form or in electronic form;
• must set out the item for the agenda in full, accompanied by stated grounds justifying its inclusion or a draft resolution to be adopted at the AGM, or, if supporting an item for the agenda sent by another Shareholder, clearly identify the draft item for the agenda, which is being supported;
• must be authenticated by the person or persons making it (by identifying the Shareholder or Shareholders meeting the qualification criteria and, if in hard copy, by being signed by the Shareholder or Shareholders); and
• must be received by the Company no later than 3 April 2025 having regard to the 42-day period specified in Section 1104 of the Companies Act 2014.

14. Shareholders' right to table draft resolutions for an item on the agenda of the AGM

Under Section 1104 of the Companies Act 2014, a Shareholder or Shareholders meeting the qualification criteria set out below may table a draft resolution for items on the agenda of the AGM. The relevant request must be made by a Shareholder or Shareholders holding 3 per cent of the issued share capital, representing at least 3 per cent of the total voting rights of all the Shareholders who have a right to vote at the AGM.

The request:

• may be in hard copy form or in electronic form;
• must set out the draft resolution in full or, if supporting a draft resolution sent by another shareholder, clearly identify the draft resolution, which is being supported;and
• must be authenticated by the person or persons making it (by identifying the Shareholder or Shareholders meeting the qualification criteria and, if in hard copy, by being signed by the Shareholder or Shareholders).

A request by a Shareholder to put an item on the agenda or to table a draft resolution in respect thereof at the AGM:

• must be received by the Company no later than 3 April 2025 having regard to the 42-day period specified in Section 1104 of the Companies Act 2014. For this purpose and in accordance with Section 1104, the date of the AGM was placed on the Company's website before the end of 2024;
• must be made in one of the following ways:
  • a request in hard copy, which is signed by the Shareholder(s), states the full name and address of the Shareholder(s) and is sent to the Company Secretary, Irish Residential Properties REIT plc, South Dock House, Hanover Quay, D02 XW94, Dublin 2, Ireland; or
  • a request in electronic form, which states the full name and address of the Shareholder(s) and is sent to companysecretary@iresreit.ie; and
• must, if tabling a draft resolution, not be of such a nature as would be incapable of being passed or otherwise be ineffective (whether by reason of inconsistency with any enactment or the Company's Constitution or otherwise) and must not be defamatory of any person.

15. Postponement of the AGM

Article 59(e) of the Company's Articles of Association provide that if the Directors, in their absolute discretion, consider that it is impractical or unreasonable for any reason to hold a general meeting on the date or at the time or place specified in the notice calling the general meeting, they may postpone the general meeting to another date, time and place. When a meeting is so postponed, notice of the date, time and place of the postponed meeting shall be placed in at least two national newspapers in Ireland. Notice of the business to be transacted at such postponed meeting shall not be required.

Any such changes or updates regarding the AGM (including any updates or changes regarding any postponement, change in time or place) will also be notified to Shareholders on the Company's website at www.iresreit.ie. Shareholders are encouraged to check this website regularly for any such updates or changes in advance of the AGM as circumstances may change at short notice.